1/13
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
Non-Selective alpha-Antagonists (α1 and α2) list
imidazoline derivatives (phentolamine), beta-chloroethylamine derivative
Imidazoline derivatives SAR
1. 2 aromatic rings – increased bulk, decreased intrinsic activity (promotes antagonism)
2. No “ortho” substituents on the Ar rings (allows for free rotation of the aromatic rings). Results in loss of α selectivity and increased antagonist action
carbon and nitrogen bridging members also contribute to non-selectivity
beta-chloroethylamine derivative
phenoxybenzamine hydrochloride
beta-chloroethylamine derivative SAR
irreversible alpha-antagonist by forming a covalent bond with a receptor nucleophile (due to nucleophile N and electrophile mechanism that sucks), causes aziridinium formation
Selective α1 Antagonists list
Quinazolines (peripheral antihypertensives), Alfuzosin
Quinazolines (peripheral antihypertensives) SAR
piperazine attached to amide (susceptible to amide hydrolysis)
Increased steric bulk (addition of flat with bulk) protects the terminal amide group from hydrolysis and may contribute to increased half-life and duration of action
Structural differences arise from the nature of the aryl group attached to the amide carbonyl
Quinazolines from shortest to longest acting
prazosin → terazosin → doxazosin
Alfuzosin special SAR (from quinazolines)
• Piperazine ring at the 3-position replaced by diamino containing chain at the 3-position instead of the piperazine.
Selective alpha-1A Antagonists
Phenethylamines
Phenethylamines SAR
• Phenethylamine present
• Aralkyl-like substituent on the basic nitrogen (α-antagonism)
• Methyl group on the α-carbon atom (increases α1-receptor selectivity)
• Polar groups (amide, sulfonamide, phenol, amino) on the aromatic ring
MOA of mirtazepine
Enhances NE release by blocking presynaptic receptor (due to insane bulk)
Blocking the presynaptic receptor causes increased neurotransmitter biosynthesis, increased neurotransmitter release, and decreased uptake of NE.
This results in increased NE neurotransmission. Used as an antidepressant.
target for drug action of quinazolines
a1 receptors in peripheral vasculature
target of drug action of selective alpha 2 antagonists
PRESYNAPTIC alpha 2 receptors
selective alpha 2 antagonists SAR
still phenethylamine present
ionizable amine
lots of ring system bulk that’s clustered together (tries to make smaller to fit into presynaptic receptor)